LGND

Question 1

Who is the CEO of Ligand Pharmaceuticals Inc?

Accepted Answer

Mr. Todd Davis is the Chief Executive Officer of Ligand Pharmaceuticals Inc, joining the firm since 2007.

Question 2

What is the price performance of LGND stock?

Accepted Answer

The current price of LGND is $202.45, it has increased 1.05% in the last trading day.

Question 3

What are the primary business themes or industries for Ligand Pharmaceuticals Inc?

Accepted Answer

Ligand Pharmaceuticals Inc belongs to Pharmaceuticals industry and the sector is Health Care

Question 4

What is Ligand Pharmaceuticals Inc market cap?

Accepted Answer

Ligand Pharmaceuticals Inc's current market cap is $3.9B

Question 5

Is Ligand Pharmaceuticals Inc a buy, sell, or hold?

Accepted Answer

According to wall street analysts, 10 analysts have made analyst ratings for Ligand Pharmaceuticals Inc, including 4 strong buy, 8 buy, 1 hold, 0 sell, and 4 strong sell

Ligand Pharmaceuticals Inc (LGND) Price

LGND Stock Price Chart

Related News

SQM Leads Value Stocks With 36.7% Estimated Discount

Ligand Pharmaceuticals Issues Strong 2026 Financial Guidance

Follow-Up Questions

Who is the CEO of Ligand Pharmaceuticals Inc?

What is the price performance of LGND stock?

What are the primary business themes or industries for Ligand Pharmaceuticals Inc?

What is Ligand Pharmaceuticals Inc market cap?

Is Ligand Pharmaceuticals Inc a buy, sell, or hold?

Follow-Up Questions

Who is the CEO of Ligand Pharmaceuticals Inc?

What is the price performance of LGND stock?

What are the primary business themes or industries for Ligand Pharmaceuticals Inc?

What is Ligand Pharmaceuticals Inc market cap?

Is Ligand Pharmaceuticals Inc a buy, sell, or hold?

Related News

SQM Leads Value Stocks With 36.7% Estimated Discount

Ligand Pharmaceuticals Issues Strong 2026 Financial Guidance